MedTrace Logo

Acetazolamide for the Prevention of High Altitude Illness: a Comparison of Dosing

NCT01993667 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2019-01-29

Study results available
· View outcomes & findings →

Summary

This is a phase 4, randomized, double-blinded interventional trial comparing alternative doses of Acetazolamide for the prevention of High Altitude Illness.

Conditions

  • Prophylaxis of Acute Mountain Sickness

Interventions

DRUG

Low Dose Acetazolamide

Administration of low dose acetazolamide

DRUG

Normal Dose Acetazolamide

Administration of normal dose acetazolamide

Sponsors & Collaborators

Principal Investigators

  • McIntosh Scott, MD · University of Utah

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2016-11-30
Completion
2016-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01993667 on ClinicalTrials.gov